Carl Zeiss Meditec AG | Deep Dive | Justus Felix Wehmer, CFO

Welcome to seat11a, in today’s video we are presenting Justus Felix Wehmer, CFO at Carl Zeiss Meditec Join Justus in the Big Conversation. In this video Justus will guide you through the following topics: 00:00 Carl Zeiss Meditec 00:11 Please briefly introduce yourself. 00:57 Please describe some key factors that make Carl Zeiss Meditec an attractive investment. 02:11 Who is your parent company and what’s the relationship with them? 03:14 Can you describe your business units and underlying markets? 5:00 What are growth drivers in ophthalmic surgery? 5:55 Can you talk about the opportunity you see in digitalization? 07:29 What’s the competitive Landscape like by market and segment? 09:37 Can you describe your key geographic Exposures / Portfolio by Region? 11:08 What are the opportunities and risks in China? 13:34 What’s the growth opportunity in the US market? 15:34 What are the M&A opportunities in your sector? 16:34 What is your latest financial outlook? Company Profile The Medical Technology activities of ZEISS are bundled under the umbrella of the MDAX- and TecDAX-listed company Carl Zeiss Meditec AG. With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world in major markets. The company can also exploit the Carl Zeiss group`s powerful global distribution network. Two Pillars of Business & Markets: The main activities of Carl Zeiss Meditec AG are located in the field of Ophthalmology and Microsurgery In Ophthalmology, the Company offers mainly products and solutions for the diagnosis and treatment of eye diseases, as well as systems and consumables for cataract, retinal and refractive surgery. In Microsurgery the Carl Zeiss Meditec Group provides visualization solutions for minimally invasive surgical treatments. Markets: The Carl Zeiss Meditec Group has operations all over the world. With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world’s most important markets. Milestones & Innovations: Research and development plays an important role within the Carl Zeiss Meditec Group. Our objective is to enable our customers and physicians to continuously improve treatment results through improvements in efficiency and innovative new products ---------------------------- ▶️ Visit us: https://seat11a.com/ ---------------------------- ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relation... Company Presentation: https://seat11a.com/investor-relation... Deep Dive Presentation: https://seat11a.com/investor-relation... Financial Results Presentation: https://seat11a.com/investor-relation... ESG Presentation: https://seat11a.com/investor-relation... ----------------------------- ▶️ About seat11a: Seat11a is the next-generation roadshow for listed companies. We democratize financial intelligence by offering listed companies an investor video platform to address their message to Institutional and Professional Investors anywhere, anytime. ----------------------------- ✅ Disclaimer: this publication is just for informational purposes only – it is not considered to give any investment advice! You agree to www.seat11a.com/legal/ and www.seat11a.com/imprint/